Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma.

Abstract:

:Transcriptomic phenotypes defined for melanoma have been reported to correlate with sensitivity to various drugs. In this study, we aimed to define a minimal signature that could be used to distinguish melanoma sub-types in vitro, and to determine suitable drugs by which these sub-types can be targeted. By using primary melanoma cell lines, as well as commercially available melanoma cell lines, we find that the evaluation of MLANA and INHBA expression is as capable as one based on a combined analysis performed with genes for stemness, EMT and invasion/proliferation, in identifying melanoma subtypes that differ in their sensitivity to molecularly targeted drugs. Using this approach, we find that 75% of melanoma cell lines can be treated with either the MEK inhibitor AZD6244 or the HSP90 inhibitor 17AAG.

journal_name

Medchemcomm

journal_title

MedChemComm

authors

Senses KM,Ghasemi M,Akbar MW,Isbilen M,Fallacara AL,Frankenburg S,Schenone S,Lotem M,Botta M,Gure AO

doi

10.1039/C6MD00466K

subject

Has Abstract

pub_date

2017-01-01 00:00:00

pages

88-95

issue

1

eissn

2040-2503

issn

2040-2511

journal_volume

8

pub_type

杂志文章
  • A systematic analysis of atomic protein-ligand interactions in the PDB.

    abstract::As the protein databank (PDB) recently passed the cap of 123 456 structures, it stands more than ever as an important resource not only to analyze structural features of specific biological systems, but also to study the prevalence of structural patterns observed in a large body of unrelated structures, that may refle...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c7md00381a

    authors: Ferreira de Freitas R,Schapira M

    更新日期:2017-10-01 00:00:00

  • Targeting the trehalose utilization pathways of Mycobacterium tuberculosis.

    abstract::Tuberculosis (TB) is an epidemic disease and the growing burden of multidrug-resistant (MDR) TB world wide underlines the need to discover new drugs to treat the disease. Mycobacterium tuberculosis (Mtb) is the etiological agent of most cases of TB. Mtb is difficult to treat, in part, due to the presence of a sturdy h...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C5MD00376H

    authors: Thanna S,Sucheck SJ

    更新日期:2016-01-01 00:00:00

  • Antifungal amphiphilic kanamycins: new life for an old drug.

    abstract::Classical aminoglycoside antibiotics are obsolete or hampered by the emergence of drug resistant bacteria. Recent discoveries of antifungal amphiphilic kanamycins offer new strategies for reviving and repurposing these old drugs. A simple structural modification turns the clinically obsolete antibacterial kanamycin in...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c8md00155c

    authors: Subedi YP,AlFindee MN,Takemoto JY,Chang CT

    更新日期:2018-04-17 00:00:00

  • Toxicity of tryptophan manganese(i) carbonyl (Trypto-CORM), against Neisseria gonorrhoeae.

    abstract::The potential for carbon monoxide-releasing molecules (CO-RMs) as antimicrobials represents an exciting prospective in the fight against antibiotic resistance. Trypto-CORM, a tryptophan-containing manganese(i) carbonyl, is toxic against E. coli following photo-activation. Here, we demonstrate that Trypto-CORM is toxic...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c6md00603e

    authors: Ward JS,Morgan R,Lynam JM,Fairlamb IJS,Moir JWB

    更新日期:2016-12-06 00:00:00

  • Facilitating the presentation of antigen peptides on dendritic cells for cancer immunotherapy using a polymer-based synthetic receptor.

    abstract::The introduction of proteins into dendritic cells (DCs) ex vivo is a critical step for the DC-based immunotherapy of cancer. Here, we developed a biotin-modified polymer with multiple hydrophobic membrane anchors for cells that functions as a synthetic receptor for an antigen protein, ovalbumin (OVA), to introduce it ...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c7md00188f

    authors: Li C,Takeo M,Matsuda M,Nagai H,Xizheng S,Hatanaka W,Kishimura A,Inoue H,Tani K,Mori T,Katayama Y

    更新日期:2017-05-12 00:00:00

  • Development of selective agents targeting serotonin 5HT1A receptors with subnanomolar activities based on a coumarin core.

    abstract::A series of 18 new 5-[3-(4-aryl-1-piperazinyl)propoxy]coumarin derivatives from the corresponding bromoalkyl derivatives have been designed and synthesized by us using a microwave-assisted protocol. Radioligand binding assays of this series of compounds as well as a previously synthesized series of 17 structurally-sim...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c7md00281e

    authors: Ostrowska K,Grzeszczuk D,Głuch-Lutwin M,Gryboś A,Siwek A,Dobrzycki Ł,Trzaskowski B

    更新日期:2017-07-03 00:00:00

  • Recent progress in the development of metal complexes as β-amyloid imaging probes in the brain.

    abstract::In this review, we have focused on the recent progress in metal complexes that are able to bind to β-amyloid (Aβ) species. We have discussed various radioactive complexes of 99mTc, 68Ga, 64Cu, 89Zr, and 111In, which were designed as Aβ imaging agents for positron emission tomography (PET) and single photon emission co...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c7md00064b

    authors: Chen K,Cui M

    更新日期:2017-05-16 00:00:00

  • Synthesis and pharmacological evaluation of novel selective MOR agonist 6β-pyridinyl amidomorphines exhibiting long-lasting antinociception.

    abstract::It was previously reported that 6β-aminomorphinan derivatives show high affinity for opiate receptors. Novel 6β-heteroarylamidomorphinanes were designed based on the MOR selective antagonist NAP. The 6β-aminomorphinanes were prepared with stereoselective Mitsunobu reaction and subsequently acylated with nicotinic acid...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C6MD00450D

    authors: Urai Á,Váradi A,Szőcs L,Komjáti B,Le Rouzic V,Hunkele A,Pasternak GW,Majumdar S,Hosztafi S

    更新日期:2017-01-01 00:00:00

  • Novel zafirlukast derivatives exhibit selective antibacterial activity against Porphyromonas gingivalis.

    abstract::Periodontal disease is an oral chronic immune-inflammatory disease highly prevalent worldwide that is initiated by specific oral bacterial species leading to local and systemic effects. The development of new preventive/therapeutic strategies to specifically target oral periodontopathogens without perturbing oral micr...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c9md00074g

    authors: Thamban Chandrika N,Fosso MY,Alimova Y,May A,Gonzalez OA,Garneau-Tsodikova S

    更新日期:2019-06-10 00:00:00

  • Synthesis and synergistic antifungal effects of monoketone derivatives of curcumin against fluconazole-resistant Candida spp.

    abstract::Twenty-three monoketone derivatives of curcumin were synthesized to investigate the synergy with fluconazole against fluconazole-resistant Candida spp. The minimal inhibitory concentration (MIC80) and the fractional inhibitory concentration index (FICI) of the antifungal synergist fluconazole were measured against flu...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c6md00649c

    authors: Zhao F,Dong HH,Wang YH,Wang TY,Yan ZH,Yan F,Zhang DZ,Cao YY,Jin YS

    更新日期:2017-03-17 00:00:00

  • Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents.

    abstract::Twenty-four 14-sulfonamide-tetrandrine derivatives as potential anti-cancer agents were synthesized. The synthetic derivatives were investigated for their cytotoxic activity against human cancer cell lines MDA-MB-231, PC3, WM9, HEL and K562. Initially, the IC50 values (50% inhibitory concentrations) of all of the comp...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00125a

    authors: Song J,Lan J,Chen C,Hu S,Song J,Liu W,Zeng X,Lou H,Ben-David Y,Pan W

    更新日期:2018-05-04 00:00:00

  • Astemizole-based turn-on fluorescent probes for imaging hERG potassium channel.

    abstract::Based on the scaffold of astemizole, three novel turn-on fluorescent probes (N1-N3) for human ether-a-go-go-related gene (hERG) potassium channel were developed herein. These probes have reasonable fluorescence properties, acceptable cell toxicity, and potent inhibitory activity, all of which contribute to cell imagin...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00562a

    authors: Zhang X,Liu T,Wang B,Gao Y,Liu P,Li M,Du L

    更新日期:2019-02-26 00:00:00

  • Repositioning Salirasib as a new antimalarial agent.

    abstract::Malaria is a serious tropical disease that kills thousands of people every year, mainly in Africa, due to Plasmodium falciparum infections. Salirasib is a promising cancer drug candidate that interferes with the post-translational modification of Ras. This S-farnesyl thiosalicylate inhibits isoprenylcysteine carboxyl ...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c9md00298g

    authors: Porta EOJ,Bofill Verdaguer I,Perez C,Banchio C,Ferreira de Azevedo M,Katzin AM,Labadie GR

    更新日期:2019-06-21 00:00:00

  • Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents.

    abstract::The dynamic and crucial role of tubulin in different cellular functions rendered it a promising target in anticancer drug development. Combretastatin A-4 (CA-4), an inhibitor of tubulin polymerization isolated from natural sources, is a lead molecule with significant cytotoxicity against tumour cells. Owing to its non...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c7md00227k

    authors: Seddigi ZS,Malik MS,Saraswati AP,Ahmed SA,Babalghith AO,Lamfon HA,Kamal A

    更新日期:2017-07-04 00:00:00

  • Potentiation of the Fosmidomycin analogue FR 900098 with substituted 2-oxazolines against Francisella novicida.

    abstract::A library of 33 compounds was screened for potentiation of the antibiotic FR 900098 against the Francisella tularensis surrogate Francisella novicida. From the screen a highly potent 2-oxazoline adjuvant was discovered capable of potentiating FR 900098 with a 1000-fold reduction in MIC against the Francisella sub-spec...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C6MD00365F

    authors: Stephens MD,Yodsanit N,Melander C

    更新日期:2016-01-01 00:00:00

  • Rationally synthesized coumarin based pyrazolines ameliorate carrageenan induced inflammation through COX-2/pro-inflammatory cytokine inhibition.

    abstract::In the present work, coumarin based pyrazolines (7a-g) have been synthesized and investigated for their in vitro and in vivo anti-inflammatory potential. Amongst the synthesized compounds, compounds 7a, 7d and 7f exhibited significant in vitro anti-inflammatory activity as compared to the standard etoricoxib. Keeping ...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00457a

    authors: Chandel P,Kumar A,Singla N,Kumar A,Singh G,Gill RK

    更新日期:2019-01-23 00:00:00

  • Cu(ii), Ga(iii) and In(iii) complexes of 2-acetylpyridine N(4)-phenylthiosemicarbazone: synthesis, spectral characterization and biological activities.

    abstract::In this paper, synthesis and characterization of metal complexes [Cu2(L)3]ClO4 (1), [Ga(L)2]NO3·2H2O (2) and [In(L)2]NO3·H2O (3) (HL = 2-acetylpyridine N(4)-phenylthiosemicarbazone) was carried out, including elemental analysis, spectral analysis (IR, UV-vis, NMR), and X-ray crystallography. Complex 1 contains one S-b...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c7md00415j

    authors: Wang YT,Fang Y,Zhao M,Li MX,Ji YM,Han QX

    更新日期:2017-10-09 00:00:00

  • Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity.

    abstract::Tetrahydroisoquinoline (THIQ) is a key structural component in many biologically active molecules including natural products and synthetic pharmaceuticals. Here, we report on the use of transition-metal mediated [2 + 2 + 2] cyclotrimerisation of alkynes to generate tricyclic THIQs with potential to selectively inhibit...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c9md00201d

    authors: Santos ARN,Sheldrake HM,Ibrahim AIM,Danta CC,Bonanni D,Daga M,Oliaro-Bosso S,Boschi D,Lolli ML,Pors K

    更新日期:2019-06-27 00:00:00

  • Sodium-glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class.

    abstract::Diabetes mellitus is a chronic, complex and multifactorial disease associated characteristically with hyperglycemia. One of the most recently approved antidiabetic drug classes for clinical use are sodium-glucose cotransporter type 2 (SGLT-2) inhibitors. SGLT-2 is a protein expressed in the kidneys, responsible for gl...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c8md00183a

    authors: da Silva PN,da Conceição RA,do Couto Maia R,de Castro Barbosa ML

    更新日期:2018-06-06 00:00:00

  • The use of 111Ag as a tool for studying biological distribution of silver-based antimicrobials.

    abstract::Recently, there has been an emergence of significant interest in silver-based antimicrobials. Our goal was to develop a radioactive tracer for investigating the biological fate of such compounds. Purified 111Ag was incorporated into the methylated caffeine analogue, IC1 to yield the silver carbene complex designated a...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C3MD00082F

    authors: Aweda TA,Ikotun O,Mastren T,Cannon CL,Wright B,Youngs WJ,Cutler C,Guthrie J,Lapi SE

    更新日期:2013-06-01 00:00:00

  • Kaolin alleviates the toxicity of graphene oxide for mammalian cells.

    abstract::The development of novel nanoscale vehicles for drug delivery promotes the growth of interest in investigations of interaction between nanomaterials. In this paper, we report the in vitro studies of eukaryotic cell physiological response to incubation with graphene oxide and planar kaolin nanoclay. Graphene family mat...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00633d

    authors: Rozhina E,Batasheva S,Danilushkina A,Kryuchkova M,Gomzikova M,Cherednichenko Y,Nigamatzyanova L,Akhatova F,Fakhrullin R

    更新日期:2019-06-10 00:00:00

  • Discovery of pyridyl-based inhibitors of Plasmodium falciparum N-myristoyltransferase.

    abstract::N-Myristoyltransferase (NMT) represents an attractive drug target in parasitic infections such as malaria due to its genetic essentiality and amenability to inhibition by drug-like small molecules. Scaffold simplification from previously reported inhibitors containing bicyclic cores identified phenyl derivative 3, pro...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c5md00242g

    authors: Yu Z,Brannigan JA,Rangachari K,Heal WP,Wilkinson AJ,Holder AA,Leatherbarrow RJ,Tate EW

    更新日期:2015-10-08 00:00:00

  • In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases.

    abstract::Potent, selective, and cell active small molecule kinase inhibitors are useful tools to help unravel the complexities of kinase signaling. As the biological functions of individual kinases become better understood, they can become targets of drug discovery efforts. The small molecules used to shed light on function ca...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c7md00510e

    authors: Wells CI,Kapadia NR,Couñago RM,Drewry DH

    更新日期:2017-12-08 00:00:00

  • Diazabicyclo analogues of maraviroc: synthesis, modeling, NMR studies and antiviral activity.

    abstract::Two diazabicyclo analogues of maraviroc, in which the azabicyclooctane moiety is replaced by diazabicyclooctane or diazabicyclononane, were synthesized and tested, through a viral neutralization assay, on a panel of six pseudoviruses. The diazabicyclooctane derivative maintained a significant infectivity reduction pow...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c6md00575f

    authors: Legnani L,Colombo D,Venuti A,Pastori C,Lopalco L,Toma L,Mori M,Grazioso G,Villa S

    更新日期:2016-12-16 00:00:00

  • Biochemical and microbiological evaluation of N-aryl urea derivatives against mycobacteria and mycobacterial hydrolases.

    abstract::A focused library of 24 N-aryl urea derivatives was prepared and evaluated against serine esterases of Mycobacterium tuberculosis (Mtb) Rv3802c and Mtb Ag85C. The members of the library were evaluated for both selectivity and mode of inhibition. Furan-based urea derivative 6c was found to be the most potent non-covale...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c9md00122k

    authors: Vartak A,Goins C,de Moura VCN,Schreidah CM,Landgraf AD,Lin B,Du J,Jackson M,Ronning DR,Sucheck SJ

    更新日期:2019-06-04 00:00:00

  • Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors.

    abstract::Glutamine and tyrosine-based amino acid conjugates of monocarboxylate transporter types 1 and 2 inhibitors (MCT1/2) were designed, synthesized and evaluated for their potency in blocking the proliferation of a human B lymphoma cell line that expresses the transporters Asct2, LAT1 and MCT1. Appropriate placement of an ...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C5MD00579E

    authors: Nair RN,Mishra JK,Li F,Tortosa M,Yang C,Doherty JR,Cameron M,Cleveland JL,Roush WR,Bannister TD

    更新日期:2016-05-01 00:00:00

  • Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists.

    abstract::The dopamine D3 receptor (D3R) is a proven therapeutic target for the treatment of neurological and neuropsychiatric disorders. In particular, D3R-selective ligands that can eliminate side effects associated with dopamine D2 receptor (D2R) therapeutics have been validated. However, the high homology in signaling pathw...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00237a

    authors: Cao Y,Sun N,Zhang J,Liu Z,Tang YZ,Wu Z,Kim KM,Cheon SH

    更新日期:2018-06-14 00:00:00

  • Novel lead compounds in pre-clinical development against African sleeping sickness.

    abstract::Human African trypanosomiasis (HAT), also known as African sleeping sickness, is caused by parasitic protozoa of the genus Trypanosoma. As the disease progresses, the parasites cross the blood brain barrier and are lethal for the patients if the disease is left untreated. Current therapies suffer from several drawback...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c7md00280g

    authors: Berninger M,Schmidt I,Ponte-Sucre A,Holzgrabe U

    更新日期:2017-07-31 00:00:00

  • Synthesis and biological evaluation against Leishmania donovani of novel hybrid molecules containing indazole-based 2-pyrone scaffolds.

    abstract::A series of novel indazole-pyrone hybrids were synthesized by a one pot reaction between N-alkyl-6(5)-nitroindazoles and 2-pyrone (4-hydroxy-6-methyl-2H-pyran-2-one) using indium or stannous chloride as the reducing system in the presence of acetic acid in tetrahydrofuran. The hybrid molecules were obtained in good to...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00475g

    authors: El Ghozlani M,Bouissane L,Berkani M,Mojahidi S,Allam A,Menendez C,Cojean S,Loiseau PM,Baltas M,Rakib EM

    更新日期:2018-11-19 00:00:00

  • Coupling the cell-penetrating peptides transportan and transportan 10 to primaquine enhances its activity against liver-stage malaria parasites.

    abstract::Novel primaquine-cell penetrating peptide conjugates were synthesised and tested in vitro against liver stage Plasmodium berghei parasites. Generally, the conjugates were more active than the parent peptides and, in some cases, than the parent drug. These are unprecedented findings that may open a new route towards an...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00447a

    authors: Aguiar L,Machado M,Sanches-Vaz M,Prudêncio M,Vale N,Gomes P

    更新日期:2018-11-16 00:00:00